HUE039112T2 - Gyógyszerészeti keverék antimikrobiális készítmények infúziós oldatainak elkészítéséhez; annak gyártási folyamata - Google Patents
Gyógyszerészeti keverék antimikrobiális készítmények infúziós oldatainak elkészítéséhez; annak gyártási folyamataInfo
- Publication number
- HUE039112T2 HUE039112T2 HUE12186239A HUE12186239A HUE039112T2 HU E039112 T2 HUE039112 T2 HU E039112T2 HU E12186239 A HUE12186239 A HU E12186239A HU E12186239 A HUE12186239 A HU E12186239A HU E039112 T2 HUE039112 T2 HU E039112T2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical composition
- production process
- infusion solutions
- antimicrobial preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011147170/15A RU2476206C1 (ru) | 2011-11-22 | 2011-11-22 | Фармацевтическая композиция для приготовления инфузионных растворов антимикробных препаратов, способ ее получения (варианты) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE039112T2 true HUE039112T2 (hu) | 2018-12-28 |
Family
ID=46940397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE12186239A HUE039112T2 (hu) | 2011-11-22 | 2012-09-27 | Gyógyszerészeti keverék antimikrobiális készítmények infúziós oldatainak elkészítéséhez; annak gyártási folyamata |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9889158B2 (hu) |
| EP (1) | EP2596783B1 (hu) |
| JP (1) | JP5568114B2 (hu) |
| CN (2) | CN107913250B (hu) |
| AU (1) | AU2012211402B2 (hu) |
| BR (1) | BR102012020929B1 (hu) |
| CA (1) | CA2792574C (hu) |
| CY (1) | CY1120810T1 (hu) |
| DK (1) | DK2596783T3 (hu) |
| ES (1) | ES2685222T3 (hu) |
| HR (1) | HRP20181274T1 (hu) |
| HU (1) | HUE039112T2 (hu) |
| LT (1) | LT2596783T (hu) |
| MX (2) | MX338043B (hu) |
| PL (1) | PL2596783T3 (hu) |
| PT (1) | PT2596783T (hu) |
| RS (1) | RS57578B1 (hu) |
| RU (1) | RU2476206C1 (hu) |
| SI (1) | SI2596783T1 (hu) |
| TR (1) | TR201810244T4 (hu) |
| UA (1) | UA105260C2 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2476206C1 (ru) | 2011-11-22 | 2013-02-27 | Виктор Львович Лимонов | Фармацевтическая композиция для приготовления инфузионных растворов антимикробных препаратов, способ ее получения (варианты) |
| GR1008554B (el) * | 2014-06-12 | 2015-09-03 | ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ, | Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου |
| MX2021009679A (es) | 2019-02-22 | 2021-09-10 | Catalent Uk Swindon Zydis Ltd | Minimizacion de aglomeracion, aireacion y conservacion del revestimiento de composiciones farmaceuticas que comprenden ibuprofeno. |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3252859A (en) * | 1962-10-24 | 1966-05-24 | Masti Kure Company Inc | Colloidal silica-oil composition and method of using same |
| JPS60169431A (ja) * | 1984-02-14 | 1985-09-02 | Nippon Zenyaku Kogyo Kk | β−ラクタム環を有する化合物を含有する安定な抗菌剤及びその製造法 |
| IT1243180B (it) | 1990-07-31 | 1994-05-24 | Nunzio Rapisarda | Uso della fosfomicina e dei suoi sali come agente cicatrizzante topico |
| CN1071076A (zh) * | 1991-09-26 | 1993-04-21 | 丛繁滋 | 双黄连气雾剂的制备方法 |
| FR2687071B1 (fr) | 1992-02-10 | 1995-06-23 | Exsymol Sa | Vecteur pour principe(s) actif(s) therapeutique(s) ou cosmetique(s) a usage externe et composition therapeutique ou cosmetique comprenant un tel vecteur. |
| JP3435664B2 (ja) * | 1999-12-08 | 2003-08-11 | ヤンセンファーマ株式会社 | 口腔内速崩壊型錠剤及びその製造方法 |
| KR20010097244A (ko) * | 2000-04-21 | 2001-11-08 | 유충식 | 위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법 |
| DE10149030A1 (de) * | 2001-10-05 | 2003-04-10 | Viscum Ag | Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin |
| WO2003063877A1 (en) * | 2002-02-01 | 2003-08-07 | Akzo Nobel N.V. | Cefquinome composition for intra-mammary administration in cattle |
| ES2282628T3 (es) * | 2002-04-23 | 2007-10-16 | Teva Pharmaceutical Industries Ltd. | Composicon farmaceutica que contiene particulas de lamotrigina de morfologia definida. |
| JP4695390B2 (ja) | 2002-08-09 | 2011-06-08 | アクゾ ノーベル コーティングス インターナショナル ビー ヴィ | 酸キャップされた四級化ポリマー及びそのようなポリマーを含む組成物 |
| US7563451B2 (en) | 2003-07-22 | 2009-07-21 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
| EA013864B1 (ru) * | 2008-08-29 | 2010-08-30 | Лимонова, Анастасия Викторовна | Способ повышения антимикробной активности цефалоспориновых антибиотиков |
| EA021875B1 (ru) | 2010-09-20 | 2015-09-30 | ЛИМОНОВ, Виктор Львович | Фармацевтическая композиция антимикробного и ранозаживляющего действия для наружного применения, способ ее получения |
| EA021876B1 (ru) * | 2010-09-20 | 2015-09-30 | ЛИМОНОВ, Виктор Львович | Фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, способ ее получения |
| RU2476206C1 (ru) | 2011-11-22 | 2013-02-27 | Виктор Львович Лимонов | Фармацевтическая композиция для приготовления инфузионных растворов антимикробных препаратов, способ ее получения (варианты) |
-
2011
- 2011-11-22 RU RU2011147170/15A patent/RU2476206C1/ru active
-
2012
- 2012-07-06 UA UAA201208313A patent/UA105260C2/ru unknown
- 2012-07-25 CN CN201711291851.6A patent/CN107913250B/zh active Active
- 2012-07-25 CN CN201210260661.9A patent/CN103126995B8/zh active Active
- 2012-08-01 JP JP2012170753A patent/JP5568114B2/ja not_active Expired - Fee Related
- 2012-08-06 AU AU2012211402A patent/AU2012211402B2/en not_active Ceased
- 2012-08-21 BR BR102012020929-2A patent/BR102012020929B1/pt active IP Right Grant
- 2012-09-27 SI SI201231362T patent/SI2596783T1/sl unknown
- 2012-09-27 EP EP12186239.5A patent/EP2596783B1/en active Active
- 2012-09-27 PT PT12186239T patent/PT2596783T/pt unknown
- 2012-09-27 ES ES12186239.5T patent/ES2685222T3/es active Active
- 2012-09-27 TR TR2018/10244T patent/TR201810244T4/tr unknown
- 2012-09-27 LT LTEP12186239.5T patent/LT2596783T/lt unknown
- 2012-09-27 HU HUE12186239A patent/HUE039112T2/hu unknown
- 2012-09-27 DK DK12186239.5T patent/DK2596783T3/en active
- 2012-09-27 PL PL12186239T patent/PL2596783T3/pl unknown
- 2012-09-27 RS RS20180982A patent/RS57578B1/sr unknown
- 2012-10-12 US US13/650,323 patent/US9889158B2/en active Active
- 2012-10-19 CA CA2792574A patent/CA2792574C/en active Active
- 2012-10-26 MX MX2012012486A patent/MX338043B/es active IP Right Grant
- 2012-10-26 MX MX2015005804A patent/MX364061B/es unknown
-
2015
- 2015-06-02 US US14/728,136 patent/US9844566B2/en active Active
-
2018
- 2018-08-09 HR HRP20181274TT patent/HRP20181274T1/hr unknown
- 2018-08-22 CY CY181100873T patent/CY1120810T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201405101B (en) | "new indolizine compounds, a process for their preparation and pharmaceutical compositions containing them." | |
| IL231009A (en) | The heterotromatic compounds in the oak, their preparation and their pharmaceutical preparations | |
| IL231008A0 (en) | History of thiazoles, their preparation and pharmaceutical preparations containing them | |
| EP2669289A4 (en) | QUINOLINE-LIKE COMPOUND CONTAINING A PHOSPHORUS-SUBSTITUTED GROUP, PREPARATION METHOD, MEDICAL COMPOSITION CONTAINING THE COMPOUND, AND APPLICATION | |
| ZA201208198B (en) | Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same | |
| IL275979B (en) | A process for preparing 68ga complexes | |
| HK1206938A1 (en) | Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456-- | |
| EP2742020A4 (en) | N1-CYCLIC AMIN-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| EP2885045A4 (en) | METHOD FOR MANUFACTURING DRUG DELIVERY FORMULATIONS | |
| HRP20181274T1 (hr) | Farmaceutska mješavina za pripremu infuzijskih otopina antimikrobnih pripravaka, njezin proizvodni proces | |
| EP2476420B8 (en) | Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same | |
| EP2766369A4 (en) | NOVEL SALT OF SITAGLIPTIN, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF | |
| AP3344A (en) | New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| EP2754655A4 (en) | NEW COMPOUNDS WITH ANGIOGENIC INHIBITORY EFFECT, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| EP2476419A4 (en) | PHARMACEUTICAL COMPOSITION WITH ANTIMICROBIAL AND ANTI-INFLAMMATORY EFFECT FOR PARENTERAL ADMINISTRATION AND MANUFACTURING METHOD THEREFOR | |
| IL229669A0 (en) | Process for the preparation of 1,2,3 triazole 4 carboxamide | |
| PT2802558T (pt) | Compostos com atividade antibacteriana, processo para a sua preparação, e composições farmacêuticas compreendendo os mesmos | |
| HUP1100240A2 (en) | Novel coupling process for the preparation of pharmeceutically active ingredient | |
| PL399720A1 (pl) | Zastosowanie kwasów bifenylo-4,4'-diaminobis(metylidenobisfosfonowych) do wytwarzania preparatu farmaceutycznego | |
| PL398409A1 (pl) | Zastosowanie kwasów bifenylo-4,4'-diaminobis(metylidenobisfosfonowych) do wytwarzania preparatu farmaceutycznego | |
| PL398410A1 (pl) | Zastosowanie kwasu naftylo -1,5-diaminobis(metylidenobisfosfonowego) do wytwarzania preparatu farmaceutycznego | |
| AU2011904533A0 (en) | Infusion process | |
| PL399603A1 (pl) | Sposób wytwarzania 3β,15α-dihydroksy-5α-androst-17-onu | |
| PL398413A1 (pl) | Zastosowanie kwasu fenylo-1,4-diaminobis(metylidenobisfosfonowego) do wytwarzania preparatu farmaceutycznego | |
| PL396024A1 (pl) | Sposób wytwarzania 4,2',4' -trihydroksy-6'-metoksy-3'-prenylo-α,ß-dihydrochalkonu |